Your browser doesn't support javascript.
loading
Assessing the utility of molecular diagnostic classification for cancers of unknown primary.
Moore, Elle C; Blobe, Gerard C; DeVito, Nicholas C; Hanks, Brent A; Harrison, Michael R; Hoimes, Christopher J; Jia, Jingquan; Morse, Michael A; Jayaprakasan, Parvathy; MacKelfresh, Andrew; Mulder, Hillary; Hockenberry, Adam J; Zander, Alia; Stumpe, Martin C; Michuda, Jackson; Beauchamp, Kyle A; Perakslis, Eric; Taxter, Timothy; George, Daniel J.
Affiliation
  • Moore EC; Tempus Labs, Inc, Chicago, Illinois, USA.
  • Blobe GC; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • DeVito NC; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, USA.
  • Hanks BA; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Harrison MR; Center for Cancer Immunotherapy, Duke University Medical Center, Durham, North Carolina, USA.
  • Hoimes CJ; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Jia J; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, USA.
  • Morse MA; Center for Cancer Immunotherapy, Duke University Medical Center, Durham, North Carolina, USA.
  • Jayaprakasan P; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • MacKelfresh A; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, North Carolina, USA.
  • Mulder H; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Hockenberry AJ; Center for Cancer Immunotherapy, Duke University Medical Center, Durham, North Carolina, USA.
  • Zander A; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, North Carolina, USA.
  • Stumpe MC; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Michuda J; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Beauchamp KA; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
  • Perakslis E; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
  • Taxter T; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
  • George DJ; Tempus Labs, Inc, Chicago, Illinois, USA.
Cancer Med ; 12(19): 19394-19405, 2023 10.
Article in En | MEDLINE | ID: mdl-37712677
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms, Unknown Primary / Neoplasms, Second Primary Type of study: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Med Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms, Unknown Primary / Neoplasms, Second Primary Type of study: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Med Year: 2023 Document type: Article Affiliation country: Country of publication: